American Type Culture Collection (ATCC) Logo American Type Culture Collection (ATCC) Logo Cart 0
  • Order Status
  • Careers
  • Support

Episode 48: Innovation to Application—The Next Chapter of Microphysiological Systems

Featuring Dr. Carolina Lucchesi

 

Listen on Apple Podcasts button Listen on YoutUbe Music button Listen on Spotify button Listen on Pandora button

Show Notes:

What’s next for microphysiological systems? In this episode, Dr. Carolina Lucchesi shares her perspective on how these technologies are advancing toward broader adoption in research and drug development. She discusses the potential of patient-derived models to support personalized medicine, the integration of experimental and in silico approaches, and the hurdles that remain in scaling and automation. The conversation also examines the role of MPS in improving safety and predictability—from early drug screening to infectious disease research—while offering a realistic outlook on their future impact.

Guest:

Headshot of Carolina Lucchesi, PhD

Carolina Lucchesi, PhD

Principal Scientist, BioNexus, ATCC

Carolina Lucchesi is BioNexus Foundation Principal Scientist leading the Microphysiological Systems program at ATCC. Dr. Lucchesi received her PhD in Cellular and Molecular Biology from the University of Campinas in Brazil and has over 20 years of experience in Tissue Engineering and Organ-on-Chip technology. In her current role, Dr. Lucchesi leads the MPS program bringing new capabilities in the use of advanced 3D models and developing existing and new content to be applied in state-of-art technologies.

Host:

David Yarmosh, headshot.

David Yarmosh, MS

Lead Bioinformatician, ATCC

David Yarmosh is a lead bioinformatician in ATCC’s Sequencing and Bioinformatics Center. He’s a graduate of New York University’s Tandon School of Engineering. He has been working in large data aggregation and analysis since 2013 and microbial genomics with a focus on biosurveillance R&D efforts since 2016. David has led international training exercises in Peru and Senegal, sharing metagenomic analytical capabilities. His interests include genomics database construction, metadata collection, drug resistance mechanisms, bioinformatics standards, and machine learning. Since joining ATCC in 2020, David has worked extensively in SARS-CoV-2 classification, epidemiology, and genomics evaluation, including enhanced and uniform variant reporting. He has contributed more broadly to genomics reporting and analytical standardization and he has helped develop the podcast Behind the Biology, which he now hosts.

Purple and pink sanger11 ecad 647 organoid cells.

Organoids are game changers for cancer research

See the tumor antigens